{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Motility+Disorder&page=24", "query": { "condition": "Motility Disorder", "page": 24 }, "page_size": 10 }, "pagination": { "page": 24, "page_size": 10, "total_count": 755, "total_pages": 76, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Motility+Disorder&page=25&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Motility+Disorder&page=23&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T01:44:15.947Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01616108", "title": "Bupivacaine Injection of Eye Muscles to Treat Strabismus", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Strabismus", "Esotropia", "Exotropia", "Graves Disease", "Ptosis, Eyelid" ], "interventions": [ { "name": "Bupivacaine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Smith-Kettlewell Eye Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "8 Years to 95 Years" }, "enrollment_count": 120, "start_date": "2012-04", "completion_date": "2020-09", "has_results": false, "last_update_posted_date": "2019-09-23", "last_synced_at": "2026-10-25T01:44:15.947Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01616108" }, { "nct_id": "NCT04702243", "title": "Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Primary Ciliary Dyskinesia", "Primary Immune Deficiency", "Kartagener Syndrome" ], "interventions": [ { "name": "Genetic Testing for PCD or PID", "type": "DIAGNOSTIC_TEST" }, { "name": "Unaffected Family Member Genetic Testing", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "5 Years to 45 Years" }, "enrollment_count": 436, "start_date": "2020-12-01", "completion_date": "2025-08-06", "has_results": false, "last_update_posted_date": "2025-08-21", "last_synced_at": "2026-10-25T01:44:15.947Z", "location_count": 6, "location_summary": "Palo Alto, California • Aurora, Colorado • Bethesda, Maryland + 3 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04702243" }, { "nct_id": "NCT06203106", "title": "NYSCF Scientific Discovery Biobank", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "ALS", "Amyotrophic Lateral Sclerosis", "Alzheimer Disease", "Alzheimer Disease, Early Onset", "Alzheimer Disease, Late Onset", "Batten Disease", "Corticobasal Degeneration", "Dementia", "Frontotemporal Dementia", "Huntington Disease", "Lewy Body Disease", "Multiple Sclerosis", "Multiple System Atrophy", "Parkinson Disease", "Parkinson's Disease and Parkinsonism", "Progressive Supranuclear Palsy", "INAD", "Diabetes", "Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Diabetes Mellitus, Type 1", "Macular Degeneration", "Ovarian Cancer", "Cervical Cancer", "Uterine Cancer", "Vaginal Cancer", "Vulvar Cancer", "PTSD", "Post Traumatic Stress Disorder" ], "interventions": [ { "name": "Biological Sample Collection", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "New York Stem Cell Foundation Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Days", "maximum_age": null, "sex": "ALL", "summary": "30 Days and older" }, "enrollment_count": 10000, "start_date": "2022-11-10", "completion_date": "2045-11-10", "has_results": false, "last_update_posted_date": "2025-03-03", "last_synced_at": "2026-10-25T01:44:15.947Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06203106" }, { "nct_id": "NCT02122211", "title": "Choline Dehydrogenase and Sperm Function: Effects of Betaine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Men Carrying 2 Minor Alleles for Choline Dehydrogenase rs12676", "Male Infertility" ], "interventions": [ { "name": "Betaine supplement", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "MALE", "summary": "18 Years to 60 Years · Male only" }, "enrollment_count": 6, "start_date": "2014-04", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2016-09-08", "last_synced_at": "2026-10-25T01:44:15.947Z", "location_count": 1, "location_summary": "Kannapolis, North Carolina", "locations": [ { "city": "Kannapolis", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02122211" }, { "nct_id": "NCT01641887", "title": "Decision Aid for Gastroesophageal Reflux Disease Management", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Gastroesophageal Reflux Disease", "Esophageal Cancer", "Barrett's Esophagus" ], "interventions": [ { "name": "Decision Aid", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2014-01", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2013-04-04", "last_synced_at": "2026-10-25T01:44:15.947Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01641887" }, { "nct_id": "NCT05579444", "title": "Systems Biology of Gastrointestinal and Related Diseases", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ulcerative Colitis", "Crohn Disease", "Obesity", "Colon Polyp", "Eosinophilic Esophagitis", "GERD", "Gastro Esophageal Reflux", "Barrett Esophagus", "Esophageal Cancer", "Gastritis", "Gastric Ulcer", "Duodenal Ulcer", "Intestinal Metaplasia", "Gastric Cancer", "Lymphocytic Colitis", "Microscopic Colitis", "Celiac Sprue", "IBS", "Irritable Bowel Syndrome", "SIBO", "NAFLD", "Gallstone Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Viome", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2022-11-11", "completion_date": "2023-11-29", "has_results": false, "last_update_posted_date": "2023-12-15", "last_synced_at": "2026-10-25T01:44:15.947Z", "location_count": 1, "location_summary": "Bothell, Washington", "locations": [ { "city": "Bothell", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05579444" }, { "nct_id": "NCT00378898", "title": "Feasibility of Placing Bravo PH Capsule in Proximal Esophagus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gastroesophageal Reflux Disease" ], "interventions": [ { "name": "BRAVO capsule", "type": "DEVICE" }, { "name": "Fluoroscopy", "type": "PROCEDURE" }, { "name": "sham BRAVO capsule placement", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "PROCEDURE", "OTHER" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2006-09", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2017-04-04", "last_synced_at": "2026-10-25T01:44:15.947Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00378898" }, { "nct_id": "NCT02797756", "title": "Impact of Gastroesophageal Reflux and Aspiration on Airway Inflammation and Microbiome in Children With Chronic Cough", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Cough (CC)", "Gastroesophageal Reflux (GER)" ], "interventions": [ { "name": "Esophago-gastro-duodenoscopy (EGD) with biopsy", "type": "PROCEDURE" }, { "name": "Esophageal Impedance Monitoring (EIM)", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "24 Years", "sex": "ALL", "summary": "Up to 24 Years" }, "enrollment_count": 35, "start_date": "2014-08-05", "completion_date": "2018-12-12", "has_results": false, "last_update_posted_date": "2019-01-29", "last_synced_at": "2026-10-25T01:44:15.947Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02797756" }, { "nct_id": "NCT00200044", "title": "An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gastroesophageal Reflux Disease" ], "interventions": [ { "name": "Gatekeeper Reflux Repair System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "MedtronicNeuro", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 143, "start_date": "2002-12", "completion_date": "2008-06", "has_results": false, "last_update_posted_date": "2009-07-13", "last_synced_at": "2026-10-25T01:44:15.947Z", "location_count": 10, "location_summary": "San Francisco, California • Atlanta, Georgia • Chicago, Illinois + 7 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00200044" }, { "nct_id": "NCT01162863", "title": "Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Irritable Bowel Syndrome", "Constipation" ], "interventions": [ { "name": "Lubiprostone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Smartpill wireless motility capsule", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2010-11", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2017-01-27", "last_synced_at": "2026-10-25T01:44:15.947Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01162863" } ] }